Whither Living Donors?

American Journal of Transplantation

Volumn 4, Issue 1, 2004, Pages 2-3

  Gaston, Robert S ^a   Eckhoff, Devin E ^b  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; ETHICS; EVALUATION; FLOW CYTOMETRY; HEALTH CARE UTILIZATION; HLA MATCHING; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MORBIDITY; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; T LYMPHOCYTE; TREATMENT INDICATION; TREATMENT OUTCOME;

BIOETHICS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; RISK; TISSUE AND ORGAN PROCUREMENT;

EID: 0742318930     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00329.x     Document Type: Review

References (12)

1. Murray JE. Surgery of the Soul. Canton, MA: Science History Publications/USA, 2001.
2. Murray JE, Merrill JP, Harrison JH. Renal homotransplantations in identical twins. Surgical Forum 1955; 6: 432-436.
3. Gruessner RWG, Sutherland DER, Drangstveit MB, Bland BJ, Gruessner AC. Pancreas transplants from living donors, short-and long-term outcomes. Transplant Proc 2001; 33: 819-820.
4. Sammartino C, Pham T, Panaro F et al. Successful simultaneous pancreas kidney transplantation from living-related donor against a positive crossmatch. Am J Transplant 2004; 4: 140-143.
5. Becker BN, Brazy PC, Becker YT et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end stage renal disease. Kidney Int 2000; 57: 2129-2135.
6. Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 1311-1317.
7. Laybutt DR, Glandt M, Xu G et al. Critical reduction in B-cell mass results in two distinct outcomes over time: adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 2003; 278: 2997-3005.
8. Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D, Robertson RP. Hyperproinsulinemia is associated with increased β cell demand after hemipancreatectomy in humans. J Clin Invest 1996; 97: 455-460.
9. Robertson RP, Lanz KJ, Sutherland DER, Seaquist ER. Relationship between diabetes and obesity 9-18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002; 73: 736-741.
10. Schiffman ML, Brown RS, Olthoff KM et al. Living donor liver transplantation: summary of a conference at the National Institutes of Health. Liver Transpl 2002; 8: 174-188.
11. Pascher A, Sauer IM, Walter M et al. Donor evaluation, donor risk, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transpl 2002; 8: 829-837.
12. Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL. Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant 2003; 3: 830-834.